Roceso Technologies develops wearable robotic solutions, including the EsoGlove, which assists hand movements during rehabilitation and daily activities for individuals with motor impairments. By integrating EMG biofeedback and AI-driven telerehabilitation, the company enhances the effectiveness of neurorehabilitation, promoting greater independence and quality of life for users.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals with motor impairments often require assistance during rehabilitation and daily activities to regain hand movement functionality. Traditional neurorehabilitation methods may lack the intensity and personalization needed to maximize recovery and independence.
Solution
Roceso Technologies offers a suite of wearable robotic and digital health solutions designed to enhance neurorehabilitation for individuals with motor impairments. Their product line includes the EsoGLOVE™, available in Pro and Myo versions, which provides assistance with hand movements. The CygniSENSE™ Motion is a digital therapeutic device for upper limb rehabilitation, while the CygniCONNECT™ Platform delivers AI-driven telerehabilitation. These solutions aim to improve the effectiveness of rehabilitation, promote independence, and enhance the quality of life for users through personalized and data-driven approaches.
Target Audience
The primary target audience includes individuals with motor impairments due to stroke, spinal cord injury, or other neurological conditions, as well as therapists and medical professionals in rehabilitation centers, hospitals, and clinics.
Features
- <features>
- EsoGLOVE™ Pro: An advanced neurorehabilitation system for hand rehabilitation.
- EsoGLOVE™ Myo: Integrated with EMG biofeedback module for enhanced hand rehabilitation.
- CygniSENSE™ Motion: A digital therapeutic device for upper limb rehabilitation.
- CygniCONNECT™ Platform: An AI-driven telerehabilitation platform for remote monitoring and personalized therapy.
- Wearable robotic solutions that assist hand movements during rehabilitation and daily activities.
- Integration of EMG biofeedback to tailor therapy based on real-time muscle activity.
- AI-driven telerehabilitation platform for remote monitoring and personalized therapy adjustments.